Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [ 99m Tc]Tc-ADAPT6.

MLA

Bragina, Olga, et al. “Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [ 99m Tc]Tc-ADAPT6.” Pharmaceutics, vol. 16, no. 4, Apr. 2024, p. 445. EBSCOhost, https://doi.org/10.3390/pharmaceutics16040445.

APA

Bragina, O., Tashireva, L., Loos, D., Chernov, V., Hober, S., & Tolmachev, V. (2024). Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [ 99m Tc]Tc-ADAPT6. Pharmaceutics, 16(4), 445. https://doi.org/10.3390/pharmaceutics16040445

Chicago

Bragina, Olga, Liubov Tashireva, Dmitriy Loos, Vladimir Chernov, Sophia Hober, and Vladimir Tolmachev. 2024. “Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [ 99m Tc]Tc-ADAPT6.” Pharmaceutics 16 (4): 445. doi:10.3390/pharmaceutics16040445.